Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04730180 · ClinicalTrials.gov registry record · NA
Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04730180: Clinical Trial NA study, sponsored by Stanford University.
NCT04730180 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04730180, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
We aim to learn whether use of a mixed reality device for transcranial magnetic stimulation (TMS) targeting can improve treatment outcomes compared to targeting through scalp measurements or a commercial neuronavigation system. Prior studies indicate that neuronavigation can lead to improved treatment outcomes compared to scalp measurements, but neuronavigation adaption has been lacking due to the increased burden of the neuronavigation setup on the TMS operator. We will assess whether use of a mixed reality device can decrease that burden and speed up the neuronavigation process and is feasible to be used in a clinical setting.
Interventions
- DEVICE Transcranial Magnetic Simulation
- DEVICE Mixed reality neuronavigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04730180
The ClinicalTrials.gov registry entry for NCT04730180 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Simulation is the first listed.
NCT04730180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04730180 about?
NCT04730180 is a clinical study titled "Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression". We aim to learn whether use of a mixed reality device for transcranial magnetic stimulation (TMS) targeting can improve treatment outcomes compared to targeting through scalp measurements or a commercial neuronavigation system. Prior studies indicate that neuronavigation can lead to improved treatme...
What is the current status of trial NCT04730180?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT04730180?
The interventions under investigation include: Transcranial Magnetic Simulation (DEVICE), Mixed reality neuronavigation (DEVICE).
Who is sponsoring clinical trial NCT04730180?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.